Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Aulen Pharma is a pharmaceutical company headquartered in Beijing, China, specializing in the research, development, and manufacturing of high-quality finished dosage forms. Since its inception in 2002, the company has focused on key therapeutic areas including the central nervous system (CNS), cardiovascular diseases, and anti-infectives. Aulen Pharma operates advanced GMP-certified production lines and maintains a robust portfolio of generic and branded medications such as escitalopram and amlodipine. The company is committed to providing affordable healthcare solutions while expanding its reach into international markets. Their integrated business model covers the entire pharmaceutical value chain from formulation development to commercial distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aulen Pharma.